Format

Send to

Choose Destination
Pol J Pathol. 2016 Jun;67(2):130-5.

Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.

Author information

1
Piotr Czapiewski, Department of Pathomorphology, Medical University of Gdańsk, Dębinki 7, 80-952 Gdansk, Poland, tel. +48 58 349 27 40, e-mail: czapiewskipiotr@gumed.edu.pl.

Abstract

Olfactory neuroblastoma (ONB) is a rare neoplasm of the sinonasal area with neuroendocrine differentiation. ISL-1, TTF-1 and PAX5 are transcription factors that are frequently upregulated in tumors showing neuroendocrine differentiation. The aim of our study was to evaluate these markers in a group of ONBs. We included 11 ONBs from 4 large university hospitals. Immunohistochemical expression of TTF-1, PAX5 and ISL-1 was evaluated. TTF-1, ISL-1 and PAX5 were expressed in 3/11 cases (27.27%, h-score: 3-45), 7/11 cases (63.64%, h-score: 23-200), and in 3/11 cases (27.77%, h-score 3-85), respectively. The patient with the strongest PAX5 reactivity exhibited an aggressive clinical course with rapid dissemination to the spine and death shortly after the diagnosis. No significant correlation in the expression of PAX5 and TTF-1 ( = 0.43; p = 0.18) was observed. ISL-1 is widely expressed in tumors with neuroendocrine differentiation and therefore of limited value in their differential diagnosis. TTF-1 positivity does not exclude the diagnosis of primary ONB, although usually only a small percentage of cells are positive. PAX5 expression is infrequent (27.27%) in ONB; however, if present it can be associated with a very aggressive clinical course.

PMID:
27543867
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Termedia Publishing House Ltd.
Loading ...
Support Center